⌘K

Login Start Free

Home/Filings/5/0001209191-21-008120

5//SEC Filing

Madan Ajay 5

Accession 0001209191-21-008120

CIK 0001658247other

View on SEC.gov Company Profile

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 4:48 PM ET

Size

8.4 KB

Accession

0001209191-21-008120

Insider Transaction Report

Form 5

Period: 2020-12-31

Crinetics Pharmaceuticals, Inc.CRNX

Chief Development Officer

Transactions

Other
Common Stock
2020-05-20$14.45/sh+1,470$21,242→ 77,516 total

Footnotes (1)

[F1]Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c),

Documents

2 files

Issuer

Crinetics Pharmaceuticals, Inc.

CIK 0001658247

Entity typeother

Related Parties

1

filerCIK 0001807856

Filing Metadata

Form type: 5
Filed: Feb 4, 7:00 PM ET
Accepted: Feb 5, 4:48 PM ET
Size: 8.4 KB

View on SEC.gov